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Abstract 
The epithelioid hemangioendothelioma (EH) is an uncommon angiocentric neoplasm of borderline or intermediate 
malignant potential, between the hemangioma and conventional angiosarcoma. It is characterized by the prolifera-
tion of endothelial cells with epithelioid or histiocitóide morphology with vacuolated cytoplasm and occasional 
eosinophilic spindle cells. Shows potential for local recurrence as well as the ability to metastasize. Rarely affects 
the oral cavity, it have been described from 1975 until 2008 only 27 oral cases. Morphologically the EHs may be 
confused with other lesions, from a hemangioma to a squamous cell carcinoma, and thus immunohistochemical 
analysis is required. This paper reports the clinical and immunohistochemical characteristics of a case of EH in 
the gingiva of the tooth 35 of a 17 years-old-white-female. We present a review of the clinicopathological and im-
munohistochemical characteristics of the intraoral epithelioid hemangioendothelioma cases previously reported.
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Introduction
The term hemangioendothelioma was introduced by 
Borrmann who first proposed the concept of vascular 
neoplasms with intermediate or low malignant potential 
(1). Three histological types of hemangioendothelioma 
are known: kaposiform, hobnail (or Dabska-retiform), 
and epithelioid (2).
The epithelioid hemangioendothelioma (EH) type 
was first described by Weiss and Enzinger in 1982 as 
a angiocentric neoplasm characterized by neoplastic 
proliferation of epithelioid or histiocytoid endothelial 
cells, showing eosinophilic vacuolated cytoplasm, and 
occasionally, fusiform cells. The cell proliferation can 
be arranged as short anastomosing cords, solid lobules 
or lining distinct primitive-appearing vascular chan-
nels, with erythrocytes occasionally seen in the lumina. 
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Frequently, the tumor cells are arranged within a fibro-
myxoid stroma (3). 
This tumor primarily committed to the soft tissues of 
the extremities (4), cases have been reported in lung, 
liver, bones, skin and the head and neck region, includ-
ing the oral cavity (4-6). The EH is rare in the head and 
neck region and even more rare in the oral cavity, with 
27 cases described from 1975 to 2008.
The EHs are usually treated with surgical removal of 
primary tumors, research the possibility of metastatic 
lesions and clinical follow-up of the patient due to risk 
of recurrence (7).
It reported a case of intraoral epithelioid hemangioen-
dothelioma and a literature review is presented fo-
cused on clinical-pathological features and immuno-
histochemistry of the intraoral cases reported in the 
MEDLINE data base.
Case Report
A 17-year-old white woman, with 1 year history of a 
lesion in the gingiva after extraction of the 35 tooth, 
with pink color, exophytic, firm, painless, rapid growth, 
pediculated, without radiographic appearance and clini-
cal diagnosis of pyogenic granuloma. A incisional biop-
sy was performed and microscopic examination showed 
a fragment of a vascular neoplasia characterized by the 
proliferation of ovoid and fusiform endothelial cells, 
with a discrete cellular and nuclear pleomorphism, ar-
ranged in nests and cords. Some cells had an abundant 
eosinophilic cytoplasm and a hyperchromatic nuclei; 
others, sometimes, showed occasional intracytoplasmic 
vacuoles (Fig. 1A).
Cell proliferation can be seen scattered in the scanty 
stroma of lax connective tissue or limiting rudimentary 
vascular spaces, with erythrocytes occasionally seen in 
the lumina (Fig. 1B), in addition to areas with miner-
alized amorphous material between cell proliferation 
(Fig. 1C). (Table 1) shows the specifications of the anti-
bodies used. Immunopositivity was observed for CD31 
(Fig. 1D), CD34 (Fig. 2A), factor VIII-RAg (Fig. 2B), 
vimentin (Fig. 2C) and focal staining to SMA, mainly 
in myopericitics cells surrounding the neoplastic cells, 
showing endothelial differentiation (Fig. 2D). Negati-
vity was observed for EMA, S-100, cytokeratins (AE-1 
and AE-3) and CD68. 
Based on morphological and immunohistochemical 
findings, the lesion was diagnosed as epithelioid he-
mangioendothelioma. The patient is in regular follow-
up and 14 months after the surgery, no abnormalities 
were found on physical examination.
Fig. 1. A. Intense proliferation of neoplastic cells with abundant eosinophilic cytoplasm and hyperchromatic nu-
clei, and cells with occasional intracytoplasmic vacuoles, H/E – 200x; 1B. Cellular proliferation lining vascular 
structures, some of which containing erythrocytes and some cells with aspect of "signet ring-like”, H/E – 200x; 
1C. Amorphous mineralized material suggestive of metaplastic bone formation scattered between the prolifera-
tion of spindle and epithelioid neoplastic cells; 1D. Immunopositivity for CD31 in  epithelioid-like neoplastic 
endotelial cells, SABC – 100x.
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ANTIBODY CLONE SOURCE DILUITION ANTIGENIC RETRIEVAL
INCUBATION 
TIME
CD31 JC/70A Dako, CA, USA 1:40 Citrato pH 6.0, Pascal Overnight
CD34
QBEnd-
10
Dako, CA, USA 1.50 Tris EDTA pH 9, Pascal Overnight
Factor VIII F8/86 Dako, CA, USA 1:400 Citrato pH 6.0, Pascal 30 min
Vimentin V9 Dako, CA, USA 1:50 Citrato pH 6.0, Pascal 30 min
SMA asm-1 Novocastra, London, UK 1:40 Citrato pH 6.0, Pascal 60 min
EMA E29 Dako, CA, USA 1:40 Sin tratamiento 60 min
S-100 S-100 Dako, CA, USA 1:100 Citrato pH 6.0, Pascal 30 min
Cytokeratins
 (AE-1/EA-3)
A E - 1 , 
EA-3
Dako, CA, USA 1:500 Citrato pH 6.0, Pascal 120 min
CD68 KP1 Santa Cruz, CA, USA 1:50 Citrato pH 6.0, Pascal Overnight
Table 1. Specifications of the antibodies used.
Fig. 2. A. Immunopositivity for CD34 in epiteliod-like neoplastic endotelial cells, SABC-100x; 2B. Cytoplasmic immunostaining for FVIII-
RAg, SABC-400x; 2C. Immunostaining for Vimentin, SABC-400x; 2D. Immunostaining for SMA, SABC-400x.
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Discussion
The analysis of cases of intraoral epithelioid heman-
gioma reported in the literature is a relatively difficult 
task, once the lesion from years ago has received vari-
ous names, such as “hemangioendothelioma”, “malig-
nant hemangioendothelioma” and “histiocytoid heman-
gioma” (7-9), thus, the reference point selected for the 
literature review presented here is the work published in 
1975 by Wesley et al. (8), entitled “Primary malignant 
hemangioendothelioma of the gingiva”, until the most 
recent reported case by Mohtasham et al. (10).
(Table 2) shows the epidemiological data of the EHs re-
ported in the literature in journals indexed in PubMed, 
including the case reported here. Most cases were clini-
cally diagnosed as benign entities including pyogenic 
granuloma, fibroma, peripheral giant cell granuloma, 
peripheral ossifying fibroma, inflammatory fibrous hy-
perplasia and necrotizing ulcerative gingivitis (11). The 
case reported here is consistent with the literature, once 
the hypothesis of clinical diagnosis was pyogenic gran-
uloma. The fact that the majority of EHs are clinically 
diagnosed as benign lesions has a great relevance, since 
it is a neoplasm with malignant biological behavior, in-
termediate between the hemangioma and conventional 
angiosarcoma, with reported cases displaying aggres-
sive behavior and multiples recurrences (10,12).
It was noted that only 2 cases (7.4%) reported pain as-
sociated with the lesion, while the majority had no in-
formation about the symptoms, which leads us to infer 
that they were asymptomatic or that this was not just 
informed by authors (Table 2). The case reported here 
was asymptomatic. 
The analysis of radiographic features showed that 
25.9% of the lesions were associated with resorption or 
destruction of underlying bone (Table 2), highlighting 
the need for careful radiographic examination of the le-
sions to investigate possible alterations of the bone (11). 
It was not found any radiographic changes in the case 
reported here.  
The malignant potential of the EHs is not well estab-
lished, however, based on cases reported in the litera-
ture, these neoplasms exhibit a biological behavior in-
termediate between hemangioma and angiosarcoma, as 
well as potential for recurrence and metastasis (3). 
Predictions regarding the biological behavior of EH in 
the oral region are not entirely possible due to the rar-
ity of the lesion, the lack of agreement relative to ter-
minology and criteria for diagnosis of EH and because 
of differences in the biologic behavior of these tumors 
relative to both their anatomic sites and with regard to 
age of occurrence (6).
Furthermore, EH doesn t´ shows, histopathologically, 
consistent criteria for predicting their biologic behavior, 
however, it is reported that the presence of a increased 
number of mitotic figures and cellular atypia, spindle 
tumor cells, metaplastic bone formation, in addition to 
areas of focal necrosis can be morphological signs of le-
sions with more aggressive phenotype and consequently 
more reserved prognosis, with recurrences and regional 
and/or distant metastasis (1,6,11). The case reported 
here showed no relevant cellular atypia or mitotic activ-
ity, which leads us to suggest that probably could be a 
lesion with more indolent behavior.
The review of the literature showed that the most preva-
lent intraoral site for EH was the tongue (7-25.9%), fol-
lowed by the mandibular gingiva (6-22.2%) and maxil-
lary gingiva (5–18.5%). The size of lesions ranged from 
0.2 cm to 7.0 cm, with a mean of 1.7 cm. In the eight 
reported cases with recurrence (29.6%) (Table 2), it was 
noted that, in some of them, were multiple recurrences 
and the recurrent lesions showed a more aggressive ap-
pearance of malignancy. These recurrences were more 
frequent in the maxillary gingiva and buccal mucosa, 
both with 25.9%, followed by the lower lip, tongue, jaw 
and maxilla, with 12.9%, respectively. There are no re-
ports of recurrence in mandibular gingiva and this site 
is the same of the case here reported.
The case reported here agrees with the literature (3) 
regarding the histomorphological features. The lesion 
exhibit cells with prominent cytoplasmic vacuoles, 
which represent primitive-appearing vascular channels; 
it is reported that these vacuoles are negative for mu-
cin and erythrocytes occasionally seen in the lumina. 
The EHs can exhibit mineralized material, reported by 
some authors as metaplastic bone formation, in addition 
to numerous osteoclast-like giant cells. It reported that 
the metaplastic bone formation with significant cellular 
atypia, mitotic activity greater than one per 10 high-
power fields, an increased proportion of spindle tumor 
cells and focal necrosis represent histopathological fac-
tors associated with a more aggressive behavior of the 
lesion (1,13,14).
Due to the predominant morphological characteristics, 
the EHs can be confused with other lesions including 
hemangioma to squamous cell carcinoma, therefore, 
emphasizes the importance of immunohistochemical 
analysis to establish the definitive diagnosis. In this 
context, the review of published cases verified that the 
majority of intraoral EHs lesions were immunoreactive 
for CD34, CD31, factor VIII-RAg and vimentin, these 
markers characterize the epithelioid endothelial origin 
of this entity (Table 3). It is reported that the immunore-
activity for factor VIII-RAg indicates the cytoplasmatic 
luminal features and the epithelial cellular neoplastic 
nature (11). Furthermore, we agree with the literature 
that due to the morphological appearance of epithelioid 
tumoral cells of the EHs an the fact that many lesions 
are reactive for cytokeratin (AE-1/AE-3), requires a lot 
of attention from the pathologist, to avoid the risk of 
misdiagnosed as squamous cell carcinoma (13).
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A variable immunohistochemical expression to SMA for 
intraoral EHs has been observed previously (12,15,16) 
(Table 3). In the case reported here the immunoreacti-
vity for this marker was focally, as evidenced at times 
immunoreactivity in myopericitics cells surrounding 
the neoplastic cells, showing the endothelial differen-
tiation of these. The nuclear transcription factor Fli-1, 
a specific marker for Ewing’s sarcoma and primitive 
neuroectodermal tumor, has been sensitive to vascular 
lesions, including EH (15).
Considering the intermediate malignant potential of the 
EH, wide local excision was the mode of choice in most 
cases reported in the literature (6,11,15,17), it was observed 
that conservative procedures such as curettage may favor 
the recurrence of the lesions (18). Under this, after esta-
blished a diagnosis of EH the correct treatment should al-
AUTHOR (YEAR) AGE SEX LOCALIZATION
CLINICAL AND RADIOGRAPHIC 
HISTORY
FOLLOW-UP
1 Wesley  et al (1975) 18 F Mandibular gingiva Reddish erosive lesion, (34 to 36), bone resorption 2 years SFL
2 Ellis, Kratochvil (1986) 13 F Maxillary gingiva Swelling, pink, tooth mobility, 4 years 6 years SFL
3 Ellis, Kratochvil (1986) 4 F Mandibular gingiva Tooth mobility, bone resorption NI
4 Moran et al (1987) 25 F Palate Swelling, 1.0 cm, 1 year 21 months SFL
5 de Araujo et al (1987) 4 M Mandibular gingiva
Swelling,  ulceration, tooth mobility, 9 
months
NI
6 Marrogi et al (1991) 45 M Maxillary gingiva Erythematous lesion, 1.5 cm 3,6 months Rec
7 Marrogi  et al (1991) 36 F Tongue Painful nodules, 0.2 cm, 2 months 17 months SFL
8 Flaitz  et al (1995) 7 F Mandibular gingiva
Reddish swelling, 1.5 cm, tooth mobility, 
bone destruction
52 months SFL
9 Hamakawa et al (1999) 76 F
Mandibular anterior re-
gion
Submucous swelling, soft, 4.5 cm, bone 
destruction
6 years SFL
10 Orsini  et al (2001) 18 F Buccal mucosa
Asymptomatic swelling, 1.5 cm, 7 mon-
ths
9 months Rec
11 Ramer  et al (2001) 32 M Maxilla Swelling, 3.5 cm 6 months Rec
12 Molina Palma  et al (2002) 65 F Tongue Swelling ,0.5 cm, 2 months 21 months SFL
13 Machalka  et al (2003) 65 M Jawa
Swelling at the anterior region of jaw, 
tooth mobility
4.8 years Rec
14 Anderson  et al (2003) 18 F Lower lip Asymptomatic swelling, 6 months 4 months Rec
15 Chi  et al (2005) 28 F Maxillary gingiva Purple swelling, 0.6 cm 8 months SFL
16 Chi  et al (2005) 23 F Jaw 2.0 cm, bone destruction NI
17 Sun  et al (2007) 12 M Maxillary gingiva
Ulcerated swelling, 3.0 cm, 3 months, 
bone destruction, tooth mobility
6 months SFL
18 Sun  et al (2007) 53 M Buccal mucosa Swelling, 1.5, 6 months 9 months Rec
19 Sun  et al (2007) 17 M Tongue Soft swelling, 0.5 cm, 2 months 18 months SFL
20 Sun  et al (2007) 52 F Upper lip Purple swelling, 2.0 cm, 1 year 3 years SFL
21 Sun  et al (2007) 21 M Tongue Reddish swelling, 0.5 cm, 2 months 2 years SFL
22 Sun  et al (2007) 34 M Tongue Swelling, 1.0 cm, 4 months 6 years SFL
23 Sun  et al (2007) 11 M Mandibular gingiva
Painful swelling, 2.0 cm, 1 month, bone 
destruction, tooth mobility
8 years SFL
24 Sun  et al (2007) 46 M Tongue Reddish swelling, 1.2 cm 4 months Rec
25 Sun  et al (2007) 6 M Floor of mouth and tongue Reddish swelling, 7.0 cm, 6 months 2 years SL
26 Mohtasham  et al (2008) 9 M Maxillary gingiva
Ulcerated reddish swelling, asymptom-
atic, 1.0 cm, 6 months
1 year, Rec
27
Gordón-Núñez  et al 
(2008)
17 F Mandibular gingiva Swelling, pink, 2,0 cm,1 year 9 months, SFL
Table 2. Clinical and radiographic features of the intraoral EH cases reported in the literature.
M: male; F: female; NI: no information; SFL: survival free of lesion; SL: survival with lesion; Rec: recurrence.
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ways be the total surgical removal of the lesion and follow-
up, to avoid the risk of permanence of neoplastic material 
and consequently recurrence. Therapeutic modalities as 
chemo and / or radiotherapy have been suggested for the 
treatment of EH, but without satisfactory results.
Among the 27 cases of intraoral EHs reported in the 
literature, including the case of this paper was observed 
that 23 cases (85.2%) had clinical follow-up informa-
tion. Most of the patients (15-55.6%) survive free of 
evidence of lesion. On the other hand, 8 lesions (29.6%) 
recurred locally and fortunately was not registered a lo-
cal or distant metastasis, nor death associated with le-
sions (Table 2). These data reinforce the less aggressive 
nature of the intraoral EHs when compared with those 
who commit other regions of the body.
The differential diagnosis of EH with another enti-
ties that occurs at the oral cavity may be assisted by 
certain clinical, histopathological, biochemical and/
or immunohistochemistry. In this context, relates that 
epithelioid hemangioma, for example, is an lesion that 
usually exhibits cells with voluminous and eosinophilic 
cytoplasm, may be associated with lymphadenopathy 
and eosinophilia with elevated IgE and unlike the HE, 
epithelioid hemangiomas are located superficially, mul-
tilobular, not exhibit endothelial cells, cells with intra-
cytoplasmic vacuoles, atypia, mitosis and necrosis (11). 
The association of epithelioid hemangioma with lym-
phadenopathy, peripheral eosinophilia and increased 
IgE are factors that help in the differential diagnosis 
(13).
AUTHOR 
(year)
CD34 CD31 CD68
Factor 
VIII-RAg
VIMENTIN SMA S-100 EMA
AE-1/
AE-3
Fli-1 VEGF
1 Ellis, Kratochvil (1986) +
2 Ellis, Kratochvil (1986) +
3 Moran  et al (1987) +
4
Flaitz  et al 
(1995)
+
5 Hamakawa  et al (1999) + + + - - -
6 Orsini  et al (2001) +
7 Ramer  et al (2001) + +
8 Molina Palma et al (2002) + +
9 Machalka  et al (2003) + + - + + + - -
10 Chi  et al (2005) - + - - - - - +
11 Chi  et al (2005) + + - + - - - +
12 Sun  et al (2007) + + + + - - +
13 Sun  et al (2007) + + + + - - +
14 Sun  et al (2007) + + + + - - +
15 Sun  et al (2007) + + + + - - -
16 Sun  et al (2007) + + + + - - -
17 Sun  et al (2007) + + + + - - -
18 Sun  et al (2007) + + + + - - -
19 Sun  et al (2007) + + + + - - -
20 Sun  et al (2007) + + - - -
21
Mohtasham  et al 
(2008)
+ +
22 Gordón-Núñez  et al (2008) + + - + + + - - -
Table 3. Immunohistochemical analisis of the intraoral EH cases reported in the literature.
(+) Immunopositivity, (-) Immunonegativity.
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In relation to the pyogenic granuloma, the diagnosis 
can be assisted by the clinical appearance of the lobu-
lar lesion. Furthermore, the squamous cell carcinoma, 
unlike the EH, the factor VIII-RAg, Eulex and mucin 
are negative. The absence of epithelioid cells with intra-
cytoplasmic vacuoles, presence of fibrossarcoma-like 
spindle cells assist to differentiate Kaposi sarcoma of 
the EH (1). 
Based on the analysis of the literature and in the case 
reported here, we conclude that the EHs are angiosa-
rcomas whose etiology remains unknown, exhibiting 
particular histopathological and immunohistochemical 
features, being  required a careful evaluation and with 
various diagnostic techniques to recognize and treat 
properly this entity, mainly taking into account their 
relatively malignant biological behavior.
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